Ticker Short Interest

RADX Short Interest Intelligence

Radiopharm Theranostics Limited American Depositary Shares positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Bearish Conviction

Bearish Conviction

Shorts Winning

RADX is classified as Bearish Conviction. Latest reported short interest is 62.6K shares; short interest changed +45.2%, price moved -5.9% since the previous report, short interest is in the 86th percentile, and days to cover is in the 100th percentile. Trend context is weak.

Setup Score84/100Bearish Conviction
Reported Short Interest62.6K+45.2% vs prior report
Days To Cover2.55100.00 percentile
Price Reaction-5.9%since previous short report
Squeeze Pressure68crowding, trend, and pressure
Bearish Conviction84shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

68

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

84

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

92

Latest short interest is 62.6K shares and days to cover is 2.55.

Divergence

0

Short interest rose while price fell. The bearish trade is currently being confirmed by price.

Report History

RADX Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 62568 43083 45.2% 2.55 24562
15 Jun 2026 43083 50928 -15.4% 1.74 24795
29 May 2026 50928 47338 7.6% 2.18 23339
15 May 2026 47338 35793 32.3% 1.00 58180
30 Apr 2026 35793 40417 -11.4% 1.24 28775
15 Apr 2026 40417 95200 -57.6% 1.04 38979
31 Mar 2026 95200 32019 197.3% 1.00 580439

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.